Can These 2 Beaten-Down Biotechs Rebound? Cathie Wood Thinks So.
As biotech investors, we would love our favorite companies to report success with every candidate. Of course, that’s not possible. The failure of certain investigational products in clinical trials is all part of the biotech business. Still, that doesn’t…
